Kelly Tyler Ehler

Kelly Tyler Ehler appears in our data through filings on NexgenRx Inc. shares, published by SEDI. We count 14 filings; the first trade dates from 5 December 2016 and the latest from 17 June 2024.

Market trades split into 9 purchases (€50k) and 3 sales (€24k). Taken together, the purchases exceed the sales by €26k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2024, the count stands at 1 purchase and 3 sales.

Half of the purchases are above €4,614 and half below. No cluster: in 9 purchases, no other insider of the company bought within 30 days.

On 19 June 2024 came the latest disclosure, an open-market sale for €5,703 in NexgenRx Inc. The most recent open-market purchase was published on 19 June 2024, 858 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.